Theriva™ Biologics to Participate in the Q1 Investor Summit Virtual
Q1 Investor Summit Virtual Format: Presentation Presenter: Steve Shallcross, CEO and Manel Cascallo, PhD., General Director Presentation Date and Time: Tuesday, March 11, 2025, 12:30 PM ET Webcast: ...
Enlivex Therapeutics Announces Investor Webinar to Discuss Positive Interim Data from Phase I/II Allocetra™ Trial in Knee Osteoarthritis
Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, is pleased to invite investors to a live investor webinar on March 5, 2025, at ...
Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference
Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner ...